Diagnosis of hypertrophic cardiomyopathy and screening for the phenotype suggestive of gene carriage in familial disease:: a simple echocardiographic procedure

被引:8
作者
Devlin, AM
Östman-Smith, I [1 ]
机构
[1] John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England
[2] John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England
关键词
hypertrophic cardiomyopathy; M mode echocardiography; cross sectional echocardiography;
D O I
10.1136/jms.7.2.82
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives-To design a new echocardiographic method of screening for hypertrophic cardiomyopathy applicable to children and adults, with a low false positive rate in athletes. Setting-Regional centre of cardiology, Oxford, UK. Methods-Forty one patients with hypertrophic cardiomyopathy, 66 first degree relatives from families with familial hypertrophic cardiomyopathy, 262 normal subjects, and 32 athletes were studied by long axis M mode and cross sectional echocardiography to determine the frequency distribution of diastolic and systolic ratios of cardiac wall thickness to cavity diameter. Results-The best screening measure for hypertrophic cardiomyopathy is diastolic septum to cavity ratio, where a value of > 0.26 yielded a 100% disease detection rate at all ages with 0% false positives in the ordinary population. In comparison, the conventional screening tool of diastolic septum to posterior left ventricular wall ratio of > 1.5 yielded a detection rate of only 75%, for a false positive rate of 2%. In first degree relatives, a septum to cavity ratio > 0.26 yielded a 100% detection rate for an abnormal phenotype suggestive of carriage of a mutation for hypertrophic cardiomyopathy with no obvious false positives. Conventional screening showed a detection rate of only 44%. Athletes with physiological cardiac hypertrophy showed only a 6% false positive rate with diastolic septum to cavity ratio, and could be differentiated from subjects with hypertrophic cardiomyopathy by the absence of hypercontractility shown by a normal systolic left ventricular wall to cavity ratio (cut off < 0.63; 0% false positives). Conclusions-M mode echocardiographic measurement of the septum to cavity ratio provides a good screening test for hypertrophic cardiomyopathy at all ages. Combining this measurement with systolic left ventricular wall to cavity ratio improves the accuracy further.
引用
收藏
页码:82 / 90
页数:9
相关论文
共 44 条
[1]   ECHOCARDIOGRAPHIC DIAGNOSIS OF IDIOPATHIC HYPERTROPHIC CARDIOMYOPATHY WITHOUT OUTFLOW OBSTRUCTION [J].
ABBASI, AS ;
PEARCE, ML ;
MACALPIN, RN ;
EBER, LM .
CIRCULATION, 1972, 46 (05) :897-&
[2]  
ALMAHDAWI S, 1994, BRIT HEART J, V72, P105
[3]   SCREENING FOR HYPERTROPHIC CARDIOMYOPATHY [J].
CLARK, AL ;
COATS, AJS .
BMJ-BRITISH MEDICAL JOURNAL, 1993, 306 (6875) :409-410
[4]   FAMILIAL PREVALENCE AND GENETIC TRANSMISSION OF IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS [J].
CLARK, CE ;
HENRY, WL ;
EPSTEIN, SE .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (14) :709-714
[5]   Screening for hypertrophic cardiomyopathy in young athletes [J].
Corrado, D ;
Basso, C ;
Schiavon, M ;
Thiene, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (06) :364-369
[6]  
DOI YL, 1980, AM J CARDIOL, V45, P6, DOI 10.1016/0002-9149(80)90213-1
[7]   MOLECULAR AND CLINICAL ASPECTS OF INHERITED CARDIOMYOPATHIES [J].
DURAND, JB ;
ABCHEE, AB ;
ROBERTS, R .
ANNALS OF MEDICINE, 1995, 27 (03) :311-317
[8]   DIFFERENCES IN CLINICAL EXPRESSION OF HYPERTROPHIC CARDIOMYOPATHY ASSOCIATED WITH 2 DISTINCT MUTATIONS IN THE BETA-MYOSIN HEAVY-CHAIN GENE - A 908LEU-]VAL MUTATION AND A 403ARG-]GLN MUTATION [J].
EPSTEIN, ND ;
COHN, GM ;
CYRAN, F ;
FANANAPAZIR, L .
CIRCULATION, 1992, 86 (02) :345-352
[9]   PREVALENCE OF HYPERTROPHIC CARDIOMYOPATHY AND LIMITATIONS OF SCREENING METHODS [J].
FANANAPAZIR, L ;
EPSTEIN, ND .
CIRCULATION, 1995, 92 (04) :700-704
[10]   LONG-TERM MEDICAL-MANAGEMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY [J].
FRANK, MJ ;
ABDULLA, AM ;
CANEDO, MI ;
SAYLORS, RE .
AMERICAN JOURNAL OF CARDIOLOGY, 1978, 42 (06) :993-1001